« Return to News | CROs/Service Providers

Quintiles Launches New Web Site

Wednesday, October 7, 2009 07:49 AM

Quintiles launched a new web site, www.clinicalresearch.com, for those who have little or no understanding of clinical research.

“Research shows that 75% of the general public state they have little or no knowledge of clinical research and the participation process. We want to fundamentally change that statistic,” said Chris Cabell, head of Global Access to Patients at Quintiles.

“If patients and their families are more aware of the opportunities that clinical research can provide, they will be better able to make informed decisions about participating in research and helping drive the development of new and better medicines.”

Patients can identify ongoing or future clinical trials appropriate for their disease or condition and narrow them down to those that are geographically convenient.

Along with comprehensive supporting information about clinical research, including videos of patient experiences and news from recent studies, the site will allow patients to connect with other individuals about their insight into clinical research.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.